Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology
about
Cancer classification using the Immunoscore: a worldwide task forceMilk fat globule epidermal growth factor VIII signaling in arterial wall remodelingEnhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case studyBiomarkers linking PCB exposure and obesityQuality controls in cellular immunotherapies: rapid assessment of clinical grade dendritic cells by gene expression profiling.Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.Multiplexed protein analysis using encoded antibody-conjugated microbeads.Impacts of a biobank: Bridging the gap in translational cancer medicine.Gene-expression profiling in vaccine therapy and immunotherapy for cancerImmunotherapy of cancer in 2012.Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancerDendritic cell subsets as vectors and targets for improved cancer therapyWhat is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema.Dendritic cells: are they clinically relevant?Biomarkers in T cell therapy clinical trials.Multiplex serum biomarker assessments: technical and biostatistical issues.Harnessing dendritic cells to generate cancer vaccines.Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010.A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma.The immune score as a new possible approach for the classification of cancer.Translational Medicine is developing in China: a new venue for collaboration.Local immune response predicts survival in patients with thick (t4) melanomas.Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review.Turning laboratory findings into therapy: a marathon goal that has to be reached.Melanoma & biomarkers of immunoresponsiveness
P2860
Q21245495-803A2EFD-588B-4879-BD08-ABFD8BBB0448Q27013859-AA361FFE-3E2A-4168-B977-E38CF06DAB12Q28084489-22CF4320-26FF-4C51-9C38-A16DACAA7CF2Q28385829-CEA40A50-0546-48D3-B694-C0467C7DECBDQ34311362-6D6A7AE9-C065-4C19-857F-3C6F6B9DCA59Q34461524-6329B64B-8103-4077-B4BA-6707A92309A1Q35059348-BA9F02E4-346D-4471-96FA-054FE9ECB743Q35188871-28AA214A-5E9E-4843-A228-F352F2AEBDC0Q36138329-E7B505EA-4D39-47E3-8DDB-A60B21E93756Q36243536-1B50DF4C-4ABA-49C9-A4BE-C2684AE94BD5Q37670436-D0274DAE-4630-476C-A605-F75ED0B8DDE2Q37758502-9A34D956-7D39-41E4-8CE1-2DB9DB315886Q37761908-72285D57-CDED-43B9-A92E-3DC0A41F38C6Q37778692-43AA143E-7261-4BE2-8ADA-7CE9AA8D5257Q37919589-3835648A-65ED-488F-8D71-9ABE2AD1AC51Q38806499-A223E5F0-1149-4B65-B130-8FB69BE2C9E1Q41876317-FE365087-ACD2-4C61-9692-42AC9027EE5FQ41963722-122A9EA9-764E-4937-97C2-5C2018926C8EQ42113451-5209C660-937B-4FBF-A87F-0A73E86CE2D9Q42539190-334075FF-94C3-4398-AB61-045AE01C7B68Q42575734-73337004-C913-474B-B0FC-24917D9E8578Q44512595-874E1B45-E057-45AC-B10D-58750F621352Q47101079-9A3C6516-EE01-416A-AEC7-32CBE5FF8B9AQ49885285-210FF3EA-E040-415E-8591-E5D20FFEAA2EQ54956643-B61D54B8-6044-4348-B11C-EF356A8EF3D6Q58234468-0E4E8599-C5C0-4D79-8336-896DFE0C6B4B
P2860
Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Emerging concepts in biomarker ...... Molecular Markers in Oncology
@ast
Emerging concepts in biomarker ...... Molecular Markers in Oncology
@en
type
label
Emerging concepts in biomarker ...... Molecular Markers in Oncology
@ast
Emerging concepts in biomarker ...... Molecular Markers in Oncology
@en
prefLabel
Emerging concepts in biomarker ...... Molecular Markers in Oncology
@ast
Emerging concepts in biomarker ...... Molecular Markers in Oncology
@en
P2093
P2860
P50
P356
P1476
Emerging concepts in biomarker ...... Molecular Markers in Oncology
@en
P2093
A Karolina Palucka
Akira Kanamoto
Anatoli Malyguine
Benjamin Zeskind
Bernard A Fox
David F Stroncek
Emanuel F Petricoin
Francesco M Marincola
Hideaki Tahara
P2860
P2888
P356
10.1186/1479-5876-7-45
P50
P577
2009-06-17T00:00:00Z
P5875
P6179
1021946467